The Department of Pharmacology and Cancer Biology (PCB) comprises 25 primary faculty, 71 graduate students, and 33 postdoctoral fellows with complementary research interests and expertise. Ongoing research in the department addresses a myriad of important scientific questions in different areas of cancer biology, including cancer genetics and epigenetics, cancer genomics, cancer metabolism, genomic instability, cancer evolution, metastasis, targeted and immune therapies, and drug resistance. The laboratories in the Department share the common goal to integrate basic cancer research with translational and clinical studies, aiming to improve the diagnosis and treatment of human cancers.
Facilities
The Department of Pharmacology and Cancer Biology is located in the Levine Science Research Center (LSRC), one of the largest single site interdisciplinary research facilities in the United States, and in the Medical Science Research Building III (MSRB 3).
Duke University and Duke University School of Medicine offer state-of-the-art shared research facilities that are available for use by all Duke investigators. Core facilities are physically housed and administered by Duke research institutes and centers.